Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP) Oscar Arrieta, MD, Andrés F. Cardona, MD, Claudio Martín, MD, Luis Más-López, MD, Luis Corrales-Rodríguez, MD, Guillermo Bramuglia, MD, Omar Castillo-Fernandez, MD, Matthew Meyerson, MD, PhD, Eduardo Amieva-Rivera, MD, Alma Delia Campos-Parra, PhD, Hernán Carranza, MD, Juan Carlos Gómez de la Torre, MD, Yanina Powazniak, MD, Fernando Aldaco-Sarvide, MD, Carlos Vargas, MD, Mariana Trigo, MD, Manuel Magallanes-Maciel, MD, Jorge Otero, MD, Roberto Sánchez-Reyes, MD, Mauricio Cuello, MD Journal of Thoracic Oncology Volume 10, Issue 5, Pages 838-843 (May 2015) DOI: 10.1097/JTO.0000000000000481 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 Progression free survival and overall survival to EGFR TKI. Journal of Thoracic Oncology 2015 10, 838-843DOI: (10.1097/JTO.0000000000000481) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions